Carriers of BRCA1 germline pathogenic variants have a significantly high lifetime risk of breast cancer – up to 72%, whereas BRCA2 carriers have a slightly lower but still a substantial risk of around 69% [3]. This evidence concerns the gene BRCA1 and breast cancer.